אינפנריקס

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

DIPHTHERIA TOXOID; FILAMENTOUS HAEMAGGLUTININ (FHA); PERTACTIN; PERTUSSIS TOXOID (PT); TETANUS TOXOID

Available from:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC code:

J07CA

Pharmaceutical form:

תרחיף להזרקה

Composition:

DIPHTHERIA TOXOID NLT 30 IU; TETANUS TOXOID NLT 40 IU; PERTACTIN 8 MCG / 0.5 ML; FILAMENTOUS HAEMAGGLUTININ (FHA) 25 MCG / 0.5 ML; PERTUSSIS TOXOID (PT) 25 MCG / 0.5 ML

Administration route:

תוך-שרירי

Prescription type:

מרשם נדרש

Manufactured by:

GLAXO SMITH KLINE BIOLOGICALS S.A

Therapeutic group:

BACTERIAL AND VIRAL VACCINES, COMBINED

Therapeutic indications:

Infanrix is indicated as a booster dose for children 15 months to 7 years of age who have previously been immunised with three or four doses of either DTPa vaccine or diphtheria, tetanus and whole-cell pertussis (DTPw) vaccine. Active primary immunisation against diphteria, tetanus and pertussis from the age 2 months onward.

Authorization date:

2012-01-31